$placeNoAds is not true
placeAds(In the Statement, class 5 has been corrected per the Restriction dated January 17, 2019, and the Fnote dated January 26, 2019.;Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for pharmaceutical medicinal use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic agents for medical imaging [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient ];In the Statement, class 5 has been corrected per the Restriction and the Fnote dated January 22, 2021.;Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;Research and development services relating to pharmaceutical products;, 'body') is not true
ALBUMEDIX Brand - FindOwnerSearch

ALBUMEDIX

Welcome to the Brand page for “ALBUMEDIX”, which is offered here for In the statement, class 5 has been corrected per the restriction dated january 17, 2019, and the fnote dated january 26, 2019.;pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for pharmaceutical medicinal use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic agents for medical imaging [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient ];in the statement, class 5 has been corrected per the restriction and the fnote dated january 22, 2021.;chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;research and development services relating to pharmaceutical products;.

Its status is currently believed to be active. Its class is unavailable. “ALBUMEDIX” is believed to be currently owned by “ALBUMEDIX LTD”.


Owner:
ALBUMEDIX LTD
Owner Details
Description:
In the Statement, class 5 has been corrected per the Restriction dated January 17, 2019, and the Fnote dated January 26, 2019.;Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for pharmaceutical medicinal use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic agents for medical imaging [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient ];In the Statement, class 5 has been corrected per the Restriction and the Fnote dated January 22, 2021.;Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;Research and development services relating to pharmaceutical products;
Categories: STATEMENT